Jointly sponsored by the Perelman School of Medicine at the University of Pennsylvania and ViralEd, Inc.
 
CME INFORMATION PAGE
Series Overview:
The Perelman School of Medicine at the University of Pennsylvania and ViralEd are proud to present the Viral Hepatitis Grand Rounds. This program is based on the ground-breaking CME activity "HIV Grand Rounds" which, in partnership with the Perelman School of Medicine at the University of Pennsylvania, is preparing for its fourth year running. These CME-certified sessions combine traditional academic grand rounds with the innovation and convenience of telemedicine. The "Viral Hepatitis Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania" is delivered live via the Internet every second and fourth Wednesday of each month at 12:00pm Eastern Time and are available for on-demand viewing immediately following the live broadcast.
Presentations cover the most important and current topics in Hepatitis and are delivered by the top experts in the field. They are designed to be immediately relevant to practicing Hepatitis clinicians and many are case-based. The final 10 minutes of each one-hour educational activity consists of a live question and answer period, with the presenting faculty member available to answer questions asked by attendees using the webinar interface. These monthly grand rounds are intended to provide clinicians with convenient and easily accessible knowledge and clinical skills they need to provide the best medical care for their Hepatitis patients.
Each session may be broadcast via your Internet connection in your conference room or auditorium for large groups to view, or individually to your personal computer at your convenience. Simply register at www.viraled.com/hepatitisgrandrounds for easy access.
Target Audience:
The program has been designed for physicians, fellows, residents, medical students, nurses, nurse practitioners, physician assistants and allied health professionals in the medical specialties of Hepatology, Internal Medicine, Family Practice, Gastroenterology, as well as HIV/AIDS practitioners dealing with co-infection, other Infectious Disease specialists, Public Health professionals and other clinicians interested and involved in the care of patients with Hepatitis.
Commercial Support Acknowledgement:
These activities are supported by educational grants from Gilead Sciences Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc., AbbVie Inc. and Vertex Pharmaceuticals Inc.
Learning Objectives for the Series:
Upon completion of the program, participants should be able to:
-
Improve knowledge and ability to use epidemiology and risk factors for viral hepatitis.
-
Increase the rate of testing of viruses associated with hepatitis.
-
Improve knowledge, competence and clinical practice in terms of the current standards and guidelines for the management of patients with viral hepatitis.
-
Improve their treatment of viral hepatitis in patient co-infected with HIV or other viral infections.
Course Directors:
 |
K. Rajender Reddy, MD
Professor of Medicine
Professor of Medicine in Surgery
Director of Hepatology
Director of Viral Hepatitis Center
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
|
 |
Mark S. Sulkowski, MD
Professor of Medicine
Medical Director, Viral Hepatitis Center
Johns Hopkins University School of Medicine
Baltimore, Maryland
|
Back to Top
FACULTY VHGR1:
 |
John W. Ward, MD
Director, Division of Viral Hepatitis
National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention
Centers for Disease Control and Prevention
Atlanta, Georgia
|
 |
Andrew J. Muir, MD, MHS
Associate Professor of Medicine
Division of Gastroenterology
Director, Gastroenterology/Hepatology Research
Duke Clinical Research Institute
Duke University School of Medicine
Durham, North Carolina
|
 |
Marion G. Peters, MD
John V. Carbone MD Endowed Chair
Professor of Medicine
Chief of Hepatology Research
University of California
San Francisco, California
|
 |
Kenneth E. Sherman, MD, PhD
Gould Professor of Clinical Medicine
Director, Division of Digestive Diseases
University of Cincinnati College of Medicine
Cincinnati, Ohio
|
|
K. Rajender Reddy, MD
Professor of Medicine
Professor of Medicine in Surgery
Director of Hepatology
Director of Viral Hepatitis Center
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
|
 |
Hashem B. El-Serag, MD, MPH
Dan L. Duncan Professor of Medicine
Chief, Gastroenterology and Hepatology Section
Baylor College of Medicine
Houston, Texas
|
| Back to Top |
|
|
|
 |
Nezam H. Afdhal, MD
Professor of Medicine
Harvard Medical School
Chief of Hepatology, Director of Liver Center
Beth Israel Deaconess Medical Center
Boston, Massachusetts
|
 |
Glenn J. Treisman, MD
Professor of Psychiatry and Behavioral Sciences
Professor of Internal Medicine
Director of the AIDS Psychiatry Program
Johns Hopkins University School of Medicine
Baltimore, Maryland
|
 |
Alain H. Litwin, MD, MPH
Associate Professor of Clinical Psychiatry & Behavioral Sciences
Albert Einstein College of Medicine
Montefiore Medical Center
Bronx, New York
|
 |
Robert S. Brown Jr., MD MPH
Frank Cardile Professor of Medicine and Surgery
Chief, Center for Liver Disease and Transplantation
Columbia University College of Physicians & Surgeons
New York Presbyterian
New York, New York
|
 |
David E. Kaplan, MD MSc
Assistant Professor of Medicine at the Veteran's Administration Medical Center
Attending Gastroenterologist / Hepatologist
Philadelphia VA Medical Center
Philadelphia, Pennsylvania
|
|
Mark S. Sulkowski, MD
Professor of Medicine
Medical Director, Viral Hepatitis Center
Johns Hopkins University School of Medicine
Baltimore, Maryland
|
| Back to Top |
|
|
|
 |
Gregory T. Everson, MD FACP
Professor of Medicine
Director, Section of Hepatology
University of Colorado
Aurora, Colorado
|
 |
Michael W. Fried, MD
Professor of Medicine
Director, UNC Liver Center
University of North Carolina at Chapel Hill
Chapel Hill, NC
|
|
K. Rajender Reddy, MD
Professor of Medicine
Professor of Medicine in Surgery
Director of Hepatology
Director of Viral Hepatitis Center
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
|
|
|
| |
|
|
|
Back to top
Session Schedule and Participation Information
Presented live at 12:00 PM ET on the second and fourth Wednesdays of each month and anytime On-Demand. Beginning in March 2013, original programing will be broadcast each second and fourth Wednesday of the month at 12:00PM ET. Delivered via webinar directly to you and/or your clinic. You, or your clinic's coordinator, will receive a monthly email with topic, speaker and webinar link. Sessions can be viewed in a large conference room or auditorium for large group viewing and participation, or directly on your personal computer, tablet or smart device. If CME credit is desired for any of these sessions, proceed to http://penncmeonline.com/user/register to create your personal CME account. After your account is established and after viewing a Grand Rounds program, simply text the session code as listed in the presentation slides up to twenty-four hours after a program is broadcast (up to forty-eight hours after for the 4th week of the month session) to receive your CME credit. Back to Top
Hardware/Software Notice:
You will need Internet to participate in this activity.
Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Perelman School of Medicine at the University of Pennsylvania and ViralEd, Inc.. The Perelman School of Medicine at the University of Pennsylvania is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement:
The Perelman School of Medicine at the University of Pennsylvania designates each live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures:
It is policy at the Perelman School of Medicine at the University of Pennsylvania and ViralEd, Inc. for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provides products or services that may be relevant to the content of this continuing medical education activity. For this purpose we consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in CME, but rather to ensure that Penn CME-certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information provided to the Penn Office of CME was found to contain relationships that created a conflict of interest relative to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.
The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania (Rodman Campbell, Mila Kostic, Michael Schoen, PhD and Mindy Pollock Troy), our educational partner ViralEd, Inc. (Brian Boyle MD, Richard Gordon and Oliver Fultz), and the peer reviewer, Zalman Agus, MD, Associate Dean for Continuing Medical Education, have reported that they have no relevant financial relationships with any commercial interests related to the content of this educational activity.
Back to Top
following faculty or planning committee members have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:
| John W. Ward MD |
Kenneth E. Sherman MD PhD |
Hashem B. El-Serag, MD MPH |
David E. Kaplan, MD MSc |
| |
|
|
|
The following faculty or planning committee members have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity:
|
Presenters Name
|
Commercial Supporter
|
Relationship
|
Planning Committee Members:
|
K. Rajender Reddy, MD
|
BMS; Gilead; Vertex; Tibotec/Janssen; Merck; Genentech-Roche; Anadys; Ikaria; Hyperion
|
Contracted Research
|
| |
Merck; Genentech-Roche; Gilead; Tibotec-Jannsen; Vertex
|
Consulting Fees
|
|
Mark S. Sulkowski, MD
|
AbbVie; BIPI; BMS; Gilead; Idenix; Janssen; Merck; Vertex
|
Honorarium - Scientific Advisor
|
| |
AbbVie; BIPI; BMS; Gilead; Janssen; Merck; Vertex
|
Research
|
Faculty of on-demand programs:
|
Andrew J. Muir MD MHS
|
Abbott, Achillion, BMS, Gilead, GSK, GlobeImmune, Medtronic, Merck, Pfizer, Roche, Salix, Scynexis, Vertex Pharmaceuticals
|
Grant / Research Funding
|
| |
Achillion, BMS, Merck, Profectus BioSciences Inc., Scynexis, Vertex Pharmaceuticals
|
Consulting or Other Services (including CME)
|
|
Marian G. Peters MD
|
Biotron; Clinical Care Options; International Antiviral Society (IAS-USA);Theravance 2012
|
Advisory Board Member
|
| |
International Antiviral Society (IAS-USA); Roche
|
Speaker/honorarium
|
| |
Genentech Research and Development (Subsidiary of Roche) |
Spouse is an employee
|
|
K. Rajender Reddy MD
|
Merck, Genentech-Roche, Vertex, Gilead, Janssen, BMS
|
Ad Hoc Advisory Board
|
| |
Merck, BMS, Gilead, Vertex, Janssen, Abbott
|
Clinical Research - Support to the Institution
|
|
Nezam H. Afdhal, MD
|
Merck, GSK, Vertex, Gilead, Abbott, BMS
|
Research Support
|
| |
Merck, Gilead, Echosens, GSK, Vertex, Novartis, Boehringer Ingelheim, Ligan, Springbank, Medgenics, Kadmon
|
Consultant / Advisory Board Member
|
| |
Springbank, Medgenics |
Stock Options |
| Alain H. Litwin, MD MPH |
Kadmon Pharmaceutical |
Honorarium; Monograph Adherence
|
| |
Janssen Pharmaceutical |
Honorarium; Advisory
Committee
|
| Robert S. Brown Jr., MD MPH |
Gilead, Genentech |
Consulting & Teaching |
| Mark S. Sulkowski, MD |
AbbVie; BIPI; BMS; Gilead; Idenix; Janssen; Merck; Vertex
|
Honorarium - Scientific Advisor
|
| |
AbbVie; BIPI; BMS; Gilead; Janssen; Merck; Vertex
|
Research
|
| Gregory T. Everson, MD |
Roche/Genentech, Vertex, GlobeImmune, BMS Abbott Eisai, HGS/novartis, Pfizer, Gilead, Janssen/Tibotec |
Advisory Boards |
| |
Roche-Genentech, HGS/Novartis, BMS, Three Rivers, Vertex, Abbott |
Consulting |
| |
Merck, Centocor |
DSMB |
| |
Source, HepQuant LLC |
Stock/Ownership |
| |
HepQuant LLC |
Management |
| |
Roiche/Genentech, Schering, Vertex, GlobeImmune, Gilead, HGS/Novartis, BMS, Pfizer, Source, Eisai, GSK, Pharmassett, Ortho Biotech, Janssen/Tibotec, Medtronic |
Research Grants |
| Michael W. Fried, MD |
Genentech/Roche, Merck, Vertex, Tibotec/Janssen,
Gilead, BMS, Abbott |
Grants/Research Support |
| |
Genentech/Roche, Tibotec,/Janssen, Vertex,
Merck, Glaxo, Novartix, Abbott, Gilead, BMS |
Consultant |
| |
NIH |
Research Grants |
|
K. Rajender Reddy, MD
|
BMS; Gilead; Vertex; Tibotec/Janssen; Merck; Genentech-Roche; Anadys; Ikaria; Hyperion
|
Contracted Research
|
| |
Merck; Genentech-Roche; Gilead; Tibotec-Jannsen; Vertex
|
Consulting Fees
|
Discussion of Investigational and/or Off-label Use of Commercial Products and Devices:
The Perelman School of Medicine at the University of Pennsylvania requires all faculty to disclose any discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.
Faculty members will disclose to participants any discussions of off-label and/or investigational uses of pharmaceutical products within their presentations.
Disclaimer:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
You may contact Richard Gordon by phone at 1-856-506-5790 or by email at Rgordon@viraled.com for additional assistance.
For CME questions please contact the Perelman School of Medicine at the University of Pennsylvania Office of CME: penncme@mail.med.upenn.edu.
We look forward to bringing the highest quality, outcomes driven CME directly to you.
|
